Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...

Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that its Zephyr® Valve is now covered by Priority Health® under its ...

Spectrum Health is one of the first hospitals in Michigan to offer a novel treatment for emphysema. The treatment uses the Zephyr® Valve system, an FDA-approved minimally invasive procedure requiring ...

Connecticut COPD patients now have access to a new life-changing treatment in Hartford. The first patient at Saint Francis Hospital to get the procedure since it newly became available says it has ...

New Data Presented at ATS 2021 International Conference Shows Positive, Sustained Benefits to Patients Treated with this First Minimally Invasive, Non-drug Treatment Option REDWOOD CITY, Calif., May ...

Pulmonologists at Backus Hospital are now offering a procedure for patients with severe Chronic Obstructive Pulmonary Disease (COPD) that can greatly improve their breathing and their quality of life.

CHILLICOTHE— A new, minimally invasive procedure now being offered by Adena Health System for patients suffering from emphysema and COPD. “We’ve actually been talking about doing this type of ...

EL PASO, Texas (KFOX14/CBS4) — The Hospitals of Providence Memorial Campus performed El Paso’s first successful breakthrough lung procedureto treat patients suffering from COPD and emphysema. The ...

Bakersfield Heart Hospital is the first in Central California to offer a new lung valve treatment for patients with severe COPD/emphysema. Recently approved by the FDA under their "Breakthrough ...

REDWOOD CITY, Calif. & TOKYO--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the ...